Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
419 W Redwood St Ste 300
Baltimore, MD 21201Phone+1 667-214-1718Fax+1 410-328-5147
Summary
- A surgical oncologist, Dr. Davis specializes in the care of patients with complex and rare cancers of the digestive tract and other abdominal organs. He performs operations on the stomach, liver, pancreas and intestines using traditional and minimally invasive techniques.
Patients choose Dr. Davis because of his commitment to providing patient-centered care and high-quality cancer treatment. At the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, he provides care as part of multidisciplinary team of experts. A recognized leader in the care of patients with stomach (gastric) cancer, he has received numerous awards, including the National Cancer Institute (NCI) Director's Award in 2020.
Dr. Davis is internationally recognized as a leader in the management of people with hereditary gastric and lobular breast cancers.
Education & Training
- University of South FloridaBA, Natural Sciences, Honors, 1996 - 2020
- Indiana University School of MedicineResidency, Surgery, 2005 - 2013
- University of South Florida College of MedicineClass of 2005
- University of South FloridaBS, Biology, 2000 - 2001
Certifications & Licensure
- MD State Medical License 2017 - 2026
- NY State Medical License 2013 - 2018
- DC State Medical License 2009 - 2010
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Roux limb revision for recalcitrant bile reflux after total gastrectomy.Amber F Gallanis, Cassidy Bowden, Disha Sharma, Gracia Viana Rodriguez, Rachael Lopez
Surgery. 2025-02-15 - Sickle Trait and Alpha Thalassemia Increase NOS-Dependent Vasodilation of Human Arteries Through Disruption of Endothelial Hemoglobin-eNOS Interactions.Steven D Brooks, A Parker Ruhl, Xianke Zeng, Phillip Cruz, Sergio A Hassan
Circulation. 2025-01-07 - Adolescents and Young Adults with Germline CDH1 Variants and the Risk of Overtreatment.Amber F Gallanis, Cassidy Bowden, Rachael Lopez, Grace-Ann Fasaye, David Lang
Journal of the National Cancer Institute. 2025-01-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: